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Arterial Hypertension: Definition
• A systolic blood pressure ( SBP) >139 mmHg
and/or
• A diastolic (DBP) >89 mmHg.
• Based on the average of two or more properly 
measured, seated BP readings
• On each of two or more office visits
or
• By virtue of the patient taking antihypertensive 
medications
The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) 
and of the European Society of Cardiology (ESC) – J. Hypertension 2013; 31: 1281-1357
Classification of office BP levels (mmHg)* 
Category Systolic Diastolic
Optimal <120 and <80
Normal 120–129 and/or 80–84
High normal 130–139 and/or 85–89
Grade 1 hypertension 140–159 and/or 90–99
Grade 2 hypertension 160–179 and/or 100–109
Grade 3 hypertension ≥180 and/or ≥110
Isolated systolic hypertension ≥140 and <90
* The blood pressure (BP) category is defined by the highest level of BP, whether systolic or 
diastolic. Isolated systolic hypertension should be graded 1, 2, or 3 according to systolic BP 
values in the ranges indicated.
The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) 
and of the European Society of Cardiology (ESC) – J. Hypertension 2013; 31: 1281-1357
AH stages (WHO-ISH, 1993) 
Stage Signs
I No objective signs of organic changes
II At least one of the following signs of organ damage:
- Left ventricular hypertrophy ( x-ray film, electrocardiogram, 
echocardiogram)
- Generalized or focal narrowing of retinal masses
- Proteinuria or slightly raised plasma levels of creatinine concentrations 
(106- 107 µmol/l ), or both
- Ultrasound or radiological evidence of atherosclerotic plaque (carotid 
arteries, aorta, iliac, and femoral arteries)
III Both symptoms and signs have appeared as a result of end organ damage 
including:
- Heart: angina pectoris, myocardial infarction, heart failure
- Brain: transient ischaemic attack, stroke, hypertensive encephalopathy
- Optic fundi: retinal haemorrhages and exudates with or without 
papilloedema
- Kidney: plasma creatinine concentration >177 µmol/l, renal failure
- Vessels: dissecting aneurysm, symptomatic arterial occlusive disease
Summary of 1993 World Health Organization – International Society of Hypertension 
guidelines for the management of mild hypertension. – BMJ 1993; 307: 1541-1546
Primary  AH
• also known as essential AH
• accounts for 95% cases of 
AH
• no universally established 
cause known
Secondary AH
• less common cause of AH(5%) 
• secondary to other 
potentially rectifiable causes 
Secondary arterial hypertension
Renal parenchymal 
hypertension
Pheochromocytoma Aortic coarctation
Renovascular hypertension Hypothyroidism Brainstem vascular 
compression
Primary aldosteronism Hyperthyroidism Sleep apnea syndrome
Cushing’s syndrome Hyperparothyroidism Drug-induced 
hypertension
Pheochromocytoma
Gross pathology showing a pheochromocytoma in the adrenal medulla
https://commons.wikimedia.org/wiki/File:Adrenal_paraganglioma_clinical_Pheochromocytoma.jpg
adrenal tumor of the medulla that arise from chromaffin cells in origin, associated
with hypertension and abnormal glucose tolerance due to catecholamine excess. 
Pheochromocytoma
• Pheochromocytomas are rare, reportedly occurring 
in 0.05–0.2% of hypertensive individuals. This 
accounts for only a portion of cases, however, as 
patients may be completely asymptomatic. 
• A retrospective study from the Mayo Clinic revealed 
that in 50% of cases of pheochromocytoma, the 
diagnosis was made at autopsy.
• Approximately 10% of pheochromocytomas are 
discovered incidentally.
William F. Young. The Incidentally Discovered Adrenal Mass. N Engl J Med 2007; 356:601-610
Pheochromocytoma
Classically, pheochromocytoma manifests as spells with the
following 4 characteristics:
– Headaches
– Palpitations
– Diaphoresis
– Severe hypertension
Typical patterns of the spells are as follows:
– Frequency may vary from monthly to several times per day
– Duration may vary from seconds to hours
– Over time, spells tend to occur more frequently and 
become more severe as the tumor grows
Pheochromocytoma
• Biochemical testing via measurement of plasma free 
metanephrines or urinary fractionated metanephrines should 
be performed in patients suspected of having 
pheochromocytoma.
• Computed tomography (CT), rather than magnetic resonance 
imaging (MRI), is recommended as the first-line imaging 
technique.
Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et 
al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice 
guideline. J Clin Endocrinol Metab. 2014 Jun. 99(6):1915-42.
• Patients should be referred to specialists if a high blood 
catecholamine level, high metanephrine or 
normetanephrine level (corrected for creatinine) in a spot 
urine sample (>300 ng/mg Cr) or adrenal incidentaloma is 
noted.
The Japanese Society of Hypertension Guidelines for the Management of 
Hypertension (JSH 2009). Hypertens Res 2009; 32: 3107. 
OUR PATIENT
• Name: T.D.V.
• Sex: Male
• Age: 37 Years
• Location: Kharkiv
• Occupation: Security officer
• The name of referral institution: self-appeal
• Date of first visit: 03.11.2015
• Patient was treated as outpatient
COMPLAINTS
• Increased blood pressure, tachycardia 
episodes, sometimes headaches of pulsating 
character after trainings at the gym
• No sweating, weight loss, or postural 
hypotension
Anamnesis Morbi
• Started monitoring himself with a home blood pressure 
monitor at the age of 25 after the diagnosis of his mother 
with pheochromocytoma. BP readings did not exceed 
140/90 mm Hg. Since the age of 30 there were episodes of 
tachycardia and headaches after training in the gym. BP 
levels periodically increased up to 160/100 mm Hg, also at 
rest, without any accompanying symptoms. In 2014 was 
examined in National Institute of Therapy named by L.T. 
Malaya, where the diagnosis was made: Essential Arterial 
Hypertension, II st., with sympathetic-adrenal paroxysms. 
Normatens 1 tablet at bedtime and carvedilol 12,5 mg 2 
times daily under HR control were recommended.
• Despite this, patient believes that pheochromocytoma can 
be the cause of his complaints.
• Presently episodically takes Normatens (when SBP ≥ 160) 
and Koriol (carvedilol) in case of tachicardia. Last 2 months 
didn’t take any medications.
Anamnesis Vitae
• Professional wrestler in the past
• Works as security officer
• Smokes approximately 12 cigarettes per day.
• Feeds regularly and adequately
• Three times a week has a training in the gym
• Denied drug usage and alcohol intake
• Father died of sudden cardiac death at age 54
• Mother was diagnosed with pheochromocytoma, 
not operated
Status Presence Objectivus
• Condition is satisfactory, clear consciousness, active and not in 
distress
• Hypersthenic type of body constitution 
• Hight-168 cm, weight - 78 kg, BMI= 27.6 kg/m2
• Skin – normal pink color 
• Peripheral lymph nodes: not palpable
• Thyroid lobes are not palpable, the isthmus is palpated as a 
homogeneous smooth cross-strand, 1 cm wide 
• Musculoskeletal system examination unremarkable
• Lungs: resonance percussion note, vesicular breathing over the 
lungs fields, RR 18 bpm
• Heart borders  are not extended, heart activity is rhythmic with HR 
of  72 bpm. Heart tones are clear in all auscultating points.
• Blood pressure sin 145/100 mm Hg, dex 150/105 mm Hg
• Abdomen of normal size, painless in palpation. Liver at the costal 
margin, painless. Absence of vascular sounds during abdomen 
auscultation.
• Pasternatskiy sign is negative on both sides 
• No peripheral edema
PLAN OF SURVEY
• Full blood count
• Urinalysis
• Biochemical panel
• ECG
• EchoCG
• ABPM
• Abdominal ultrasound
• Plasma metanephrine testing
• CT scanning of the kidney, adrenal glands
Full blood count
Options Results NR
Hemoglobin 156 130,0 – 160,0 g/L
Erythrocytes 5,15 4,05 – 5,15 × 1012/L
Color index 0,9 0,85 – 1,15
Leukocytes 5,2 4,0 – 9,0 × 109/L
ESR 1 2-15mm/h
Stab neutrophils 2 1-6 %
Segmented neutrophils 58 47-72 %
Eosinophils 1 0,5-5,0%
Basophils - 1-1,0 %
Lymphocytes 33 19-37%
Monocytes 6 3-11 %
Platelets 262,7 160-320 × 109/L
Conclusion: all parameters within the normal range
Urinalysis
Options Results NR
specific gravity 1,009 1,001-1,040
pH 6,0 5,0-7,0
protein Not detected to 0.033 g / l
glucose Not detected absent
leucocytes 1-2 6-8
epithelium Not detected ≤15-20 squamous epithelial cells/hpf
bacteria Not detected absent
Conclusion: all parameters within the normal range
Biochemical panel
Options Results NR
Creatinine 88 mcmol/l 44 – 124 mcmol/l
eGFR 96 ml/min/1,73m2 > 90 ml/min/1,73m2
Urea 4,9 mmol/l 2,5 – 6,5 mmol/l
Uric asid 220 mcmol/l 210 – 428 mcmol/l
Glucose 5,4 mmol/l 4,1 – 5,5 mmol/l
Total protein 75 g/l 65 – 85 g/l
Conclusion: all parameters within the normal range
Lipid profile
Options Results NR
Total cholesterol 6,37 mmol/l ≤ 5,2 mmol / l
Very low-density lipoprotein 
cholesterol (VLDL-C)
0,37 mmol/l up to 0,77 mmol/l
Low-density lipoprotein 
cholesterol (LDL-С)
4,47 mmol/l up to 3,1 mmol/l
High-density lipoprotein 
cholesterol (HDL-C)
1,48 mmol/l 0,9 - 1,55 mmol / l
Triglycerides 0,83 mmol/l <1,7 mmol/l
Atherogenic coefficient 3,27 Up to 3,0
Conclusion: dyslipidaemia with high levels of Total cholesterol, 
Low-density lipoprotein cholesterol and increased Atherogenic 
coefficient
ECG
Conclusion: sinus rhythm with HR 70 bpm. Heart axis – horizontal 
position. Nonspecific ST-T changes in left ventricular posterior wall
Heart rate variability, breathing test
base level/breathing
The level of neurohumoral regulation (power spectral HRV) at rest is low, with the prevalence 
of humoral-metabolic regulation, which are not able to quickly provide homeostasis. Adequate 
reaction on breathing test.
Heart rate variability, breathing test
base level/rest
The nature of rhythm regulation at rest (after deep breathing) indicates a stabilization of 
heart rate with the transition of its regulation from the autonomic nervous system level to 
a lower humoral-metabolic level of regulation. Heart functionality is reduced. 
EchoCG
Index Data NR
Posterior wall (diastole), cm 1.56 0.6–1.2
LV diastolic diameter, cm 5.2 4.3–5.9
IV septum (diastole), cm 1.55 0.6–1.3
LV mass, g 365.56 men < 183 g
LVM index, g/m2 194.58 men < 115 g/m2 BSA
EF, % 60 55-60
LV – left ventricle,  IV – intraventricular, LVM – left ventricle mass, BSA – body surface area, 
EF – ejection fraction
Conclusion:
- hypertrophy of the left ventricle
- satisfactory myocardial contractility
ABPM, daily means
Indices Patient data NR
SBP, daily mean, mmHg 142 No more then 130
DBP, daily mean, mmHg 85 No more then 80
MAP, daily mean, mmHg 103 80-95
PAP, daily mean, mmHg 57 Less then 46
SBP time index, % 79.1 Less then 15
DBP time index, % 64.8 Less then 15
SBP variability, mmHg 17.4 No more then 15
DBP variability, mmHg 19.9 No more then 14
MAP variability, mmHg 17.9 no generally accepted normal values
PAP variability, mmHg 14.7 no generally accepted normal values
SBP – systolic blood pressure, DBP – diastolic blood pressure, MAP – mean arterial pressure, 
PAP – pulse arterial pressure
stable mild systolic and borderline stable diastolic 24-h 
hypertension with increased SBP and DBP variability
ABPM, awake means
Indices Patient data NR
SBP, awake mean, mmHg 147 No more then 135
DBP, awake mean, mmHg 93 No more then 85
MAP, awake mean, mmHg 110 80-95
PAP, awake mean, mmHg 54 Less then 46
SBP time index, % 84,9 Less then 15
DBP time index, % 81,5 Less then 15
SBP variability, mmHg 16.6 No more then 15
DBP variability, mmHg 17.4 No more then 14
MAP variability, mmHg 14.9 no generally accepted normal values
PAP variability, mmHg 16.0 no generally accepted normal values
SBP – systolic blood pressure, DBP – diastolic blood pressure, MAP – mean arterial pressure, 
PAP – pulse arterial pressure
stable mild systolo-diastolic awake hypertension with 
increased SBP and DBP variability
ABPM, asleep means
Indices Patient data NR
SBP, asleep mean, mmHg 129 No more then 120
DBP, asleep mean, mmHg 65 50-70
MAP, asleep mean, mmHg 84 80-95
PAP, asleep mean, mmHg 64 Less then 46
SBP time index, % 67,7 Less then 15
DBP time index, % 31,9 Less then 15
SBP variability, mmHg 12,0 No more then 15
DBP variability, mmHg 9,6 No more then 14
MAP variability, mmHg 10,0 no generally accepted normal values
PAP variability, mmHg 7,4 no generally accepted normal values
SBP – systolic blood pressure, DBP – diastolic blood pressure, MAP – mean arterial pressure, PAP 
– pulse arterial pressure
stable mild systolic asleep hypertension with DBP 
mean and SBP/DBP variability within normal ranges
ABPM, daily BP profiles
Indices Profile type Night-time decline, %
SBP Dipper 12,5
DBP Overdipper 29,8
MAP Overdipper 23,3
PAP Nightpicker - 18,5
SBP – systolic blood pressure, DBP – diastolic blood pressure, MAP – mean arterial 
pressure, PAP – pulse arterial pressure
❑ «dippers» - physiological decrease in BP during the night - sleep-time 
relative BP decline 10-20% ;
❑ «overdippers» - an excessive fall in BP at night, sleep-time relative BP 
decline > 20%;
❑ «nondippers» - the lack of BP reduction at night, sleep-time relative BP 
decline < 10%;
❑ «night-peakers» - night-time BP more than during daily activity, sleep-time 
relative BP decline < 0
Abdominal ultrasound
• The liver, gallbladder, pancreas, spleen, 
kidneys, thyroid gland - without changes, the 
pathology was not revealed
Abdominal CT scanning
The adrenal glands are located in a typical place, the 
right adrenal gland is not enlarged, legs up to 3 mm 
thick, with clear contours, homogeneous structure. 
The left adrenal gland of normal size, with irregularly 
thickened legs from 3 to 8 mm, with clear contours, 
homogeneous structure. The surrounding fatty tissue 
is not changed.
Conclusion:
CT-signs of nodular hyperplasia of left adrenal gland.
The consultation of endocrinologist was recommended


Consultation of endocrinologist
(with our comments)
• Conclusion: no data for pheochromocytoma
• We still recommended to study the level of 
catecholamines and cortisol in blood, 
however, motivating with endocrinologist 
conclusion, the patient refused any further 
examination
Risk factors Diabetes mellitus Asymptomatic organ damage
Male sex FPG ≥7.0 mmol/L (126 mg/dL) on two 
repeated measurements, and/or
Pulse pressure (in the elderly) ≥60 
mmHg
Age (men ≥55 years; women ≥65 years) HbA1c >7% (53 mmol/mol), and/or Electrocardiographic LVH, or
Smoking Post-load plasma glucose >11.0 mmol/L 
(198 mg/dL)
Echocardiographic LVH [LVM index: 
men >115 g/m2(BSA)]
Dyslipidaemia Established CV or renal disease Carotid wall thickening (IMT >0.9 mm) 
or plaque
Total cholesterol >4.9 mmol/L (190 
mg/dL), and/or
Cerebrovascular disease Carotid–femoral PWV >10 m/s
Low-density lipoprotein cholesterol >3.0 
mmol/L (115 mg/dL), and/or
CHD: MI; angina; myocardial 
revascularization with PCI or CABG
Ankle-brachial index <0.9
High-density lipoprotein cholesterol: men 
<1.0 mmol/L (40 mg/dL) and/or
Heart failure, including heart failure 
with preserved EF
CKD with eGFR 30–60 ml/min/1.73 m2 
(BSA)
Triglycerides >1.7 mmol/L (150 mg/dL) Symptomatic lower extremities 
peripheral artery disease
Microalbuminuria 
Fasting plasma glucose 5.6–6.9 mmol/L 
(102–125 mg/dL)
CKD with eGFR <30 mL/min/1.73m2 
(BSA); proteinuria (>300 mg/24 h).
Abnormal glucose tolerance test Advanced retinopathy
Obesity [BMI ≥30 kg/m2 (height2)]
Abdominal obesity (waist circumf.: men 
≥102 cm in Caucasians)
Family history of premature CVD (men 
aged <55 years; women aged <65 years)
Stratification of total CV risk
for our patient
Mancia G. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the
management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of
Cardiology (ESC) / Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz[et al.] // Journal of Hypertension. – 2013. –
Vol. 31, Is. 7. – P. 1281-1357.
Diagnosis
Arterial  hypertension presumably of 
secondary origin (pheochromocytoma?), 
Grade 2, Stage II (LVH), high risk, with an 
excessive fall in DBP at night and 
physiological degree of sleep-time relative 
SBP decline, with adequate reaction on 
breathing test, HF 0. Nodular hyperplasia of 
left adrenal gland. 
Treatment
–maintaining a healthy lifestyle
–decrease sodium intake
– lipid-lowering diet
–Diroton (lisinopril) 10 mg in the 
morning protractedly under the 
control of blood pressure level
Follow-up
• The patient was recommended to repeat the 
ABPM after 3 months, but at the appointed 
time the patient did not come. In a telephone 
conversation he said that he feels satisfactory, 
according to HBPM his BP is within 130-
140/85 mm Hg, in further examination and 
observation he is not interested. 
• It was recommended to continue Diroton 
intake, monitoring adrenal hyperplasia using 
abdominal CT-scanning yearly and 
measurements adrenal hormones in serum.

